A randomized multi-center study to evaluate the safety and efficacy of a study drug in subjects with severe sepsis
Tidswell, Mark, MD
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
The purpose of this study is to evaluate the safety and potential efficacy signal of the study drug, BMS-936559, in subjects with severe sepsis.
Eligible participants must be at least 18 years of age with proven or suspected infection as well as septic shock.